Skip to content

TRV GP VI, LLC

Follow

13F filer, CIK 1990716, Boston, MA

TRV GP VI, LLC reported $243,857,193 across 5 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.

Accepted , ingested 13F-HR 0001193125-26-463547

Period
2026-09-30
Reported value
$244M
Holdings
5
Top 10 weight
100%
New
1
Sold out
0

Part of the filer group Third Rock Ventures VI, L.P.

How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • TCXB TCGX ACQUISITION CORP II: 13G 990,000 shares, 9.5% of the class, 13G filed 2026-10-26, 0001193125-26-432002Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
LSTAnew+48,446$69.8K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001193125-26-463547, largest first. % of portfolio is the value over $243,857,193, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,152,456 shares; 2025Q1: 4,211,659 shares; 2025Q2: 4,211,659 shares; 2025Q3: 4,211,659 shares; 2025Q4: 4,211,659 shares; 2026Q1: 4,211,659 shares; 2026Q2: 4,211,659 shares; 2026Q3: 4,211,659 shares 4,211,659$165M67.58%0Timeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,061,222 shares; 2026Q3: 2,061,222 shares 2,061,222$41.6M17.05%0Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 969,218 shares; 2025Q1: 969,218 shares; 2025Q2: 969,218 shares; 2025Q3: 969,218 shares; 2025Q4: 969,218 shares; 2026Q1: 969,218 shares; 2026Q2: 969,218 shares; 2026Q3: 969,218 shares 969,218$32.6M13.35%02026-10-30, Form 4: granted 238,095 shares on 2026-10-30 Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 194,174 shares; 2025Q1: 194,174 shares; 2025Q2: 194,174 shares; 2025Q3: 194,174 shares; 2025Q4: 194,174 shares; 2026Q1: 194,174 shares; 2026Q2: 194,174 shares; 2026Q3: 194,174 shares 194,174$4.84M1.99%0Timeline
LSTALISATA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 48,446 shares 48,446$69.8K0.03%newTimeline

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-463547 base2026-11-16